HK1203353A1 - Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof - Google Patents

Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof

Info

Publication number
HK1203353A1
HK1203353A1 HK15103694.6A HK15103694A HK1203353A1 HK 1203353 A1 HK1203353 A1 HK 1203353A1 HK 15103694 A HK15103694 A HK 15103694A HK 1203353 A1 HK1203353 A1 HK 1203353A1
Authority
HK
Hong Kong
Prior art keywords
nanoparticles
metallic
preparation
hafnium oxide
oxide materials
Prior art date
Application number
HK15103694.6A
Other languages
English (en)
Chinese (zh)
Inventor
Agns Pottier
Marie-Edith Meyre
Laurent Levy
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of HK1203353A1 publication Critical patent/HK1203353A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Powder Metallurgy (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
HK15103694.6A 2011-12-16 2015-04-15 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof HK1203353A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161576437P 2011-12-16 2011-12-16
EP11193968 2011-12-16
PCT/EP2012/075731 WO2013087920A1 (fr) 2011-12-16 2012-12-17 Nanoparticules comprenant des matériaux métalliques et d'oxydes d'hafnium, leur préparation et utilisations

Publications (1)

Publication Number Publication Date
HK1203353A1 true HK1203353A1 (en) 2015-10-30

Family

ID=48611880

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103694.6A HK1203353A1 (en) 2011-12-16 2015-04-15 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof

Country Status (16)

Country Link
US (1) US10945965B2 (fr)
EP (1) EP2790682B1 (fr)
JP (1) JP6042450B2 (fr)
KR (1) KR102025743B1 (fr)
CN (1) CN104093401B (fr)
AU (1) AU2012351537B2 (fr)
BR (1) BR112014014412A2 (fr)
CA (1) CA2857260C (fr)
EA (1) EA029635B1 (fr)
HK (1) HK1203353A1 (fr)
IL (1) IL233035B (fr)
MA (1) MA35851B1 (fr)
MX (1) MX362089B (fr)
PL (1) PL2790682T3 (fr)
SG (1) SG11201403096VA (fr)
WO (1) WO2013087920A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3494974B1 (fr) 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Nanoparticules de métal-bisphosphonate pour thérapie anticancéreuse et imagerie, ainsi que pour traiter des troubles des os
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
BR112015017490A2 (pt) 2013-01-25 2017-07-11 Nanobiotix uso de nanopartículas inorgânicas
MX2015017774A (es) * 2013-06-20 2016-03-31 Nanobiotix Composiciones y metodos para el uso en el diagnostico medico.
US10806694B2 (en) * 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
WO2016061256A1 (fr) 2014-10-14 2016-04-21 The University Of Chicago Nanoparticules pour thérapie photodynamique, thérapie photodynamique induite par rayons x, radiothérapie, chimiothérapie, immunothérapie, et toute combinaison de celles-ci
TW201705977A (zh) * 2015-05-28 2017-02-16 奈諾生技公司 作為治療疫苗之奈米顆粒
US11389536B2 (en) * 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
US9607952B1 (en) * 2015-10-30 2017-03-28 International Business Machines Corporation High-z oxide nanoparticles embedded in semiconductor package
EP3439666A4 (fr) 2016-05-20 2019-12-11 The University of Chicago Nanoparticules pour chimiothérapie, thérapie ciblée, thérapie photodynamique, immunothérapie et n'importe quelle combinaison de ces dernières
KR20190105592A (ko) * 2016-12-21 2019-09-17 나노비오?스 뉴런 장애의 치료에 사용하기 위한 나노입자
WO2019028250A1 (fr) 2017-08-02 2019-02-07 The University Of Chicago Couches organométalliques nanométriques et nanoplaques organométalliques pour thérapie photodynamique induite par rayons x, radiothérapie, thérapie rodiodynamique, chimiothérapie, immunothérapie, et toute combinaison de celles-ci
JP7116563B2 (ja) * 2018-03-16 2022-08-10 株式会社日本触媒 複合粒子
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN112675305B (zh) * 2021-01-22 2023-05-23 中国科学院深圳先进技术研究院 用于肿瘤治疗的双亲性分子自组装纳米药物及制备方法和用途

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280918A (en) 1980-03-10 1981-07-28 International Business Machines Corporation Magnetic particle dispersions
US4672040A (en) 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6099457A (en) * 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
US5370901A (en) 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
JPH05209072A (ja) * 1992-01-29 1993-08-20 Japan Synthetic Rubber Co Ltd 基材の表面処理方法
EP0645048A1 (fr) 1992-06-08 1995-03-29 BioQuest Incorporated Preparation de particules inorganiques a dimensions reglables utiles dans des separations, comme commutateurs moleculaires magnetiques et comme liposomes inorganiques dans des applications medicales
JPH07509467A (ja) 1992-07-21 1995-10-19 ザ　ゼネラル　ホスピタル　コーポレーション リンパ組織への薬物輸送システム
US5395619A (en) 1993-03-03 1995-03-07 Liposome Technology, Inc. Lipid-polymer conjugates and liposomes
ATE233546T1 (de) 1997-03-07 2003-03-15 Max Delbrueck Centrum Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung
DE19716732C2 (de) 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US6200598B1 (en) 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
US6726925B1 (en) 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
AU4305101A (en) 1999-11-22 2001-06-04 Research Foundation Of The State University Of New York, The Magnetic nanoparticles for selective therapy
AU3679801A (en) 2000-02-08 2001-08-20 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
EP1401376B1 (fr) 2001-04-30 2016-11-30 Cytimmune Sciences, Inc. Compositions metalliques colloidales et procedes associes
DE10154016B4 (de) 2001-10-26 2004-02-12 Berlin Heart Ag Magnetflüssigkeit und Verfahren zur ihrer Herstellung
AU2002351240A1 (en) 2002-03-08 2003-09-22 James Hainfeld Gold nanoparticles used for x-rays imaging
US7769423B2 (en) 2002-09-11 2010-08-03 Duke University MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
US20030125283A1 (en) 2002-09-16 2003-07-03 Gatenby Robert A. Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents
US7235228B2 (en) 2003-04-15 2007-06-26 The United States Of America As Represented By The Secretary Of The Navy Fluorescent-magnetic nanoparticles with core-shell structure
US20050084869A1 (en) 2003-10-20 2005-04-21 Sung Hyun Kim Novel composition and methods for the diagnosis of lung cancer
JP2007511503A (ja) 2003-11-17 2007-05-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 医療画像化技術用の造影剤及びその使用
EP1701745B1 (fr) 2003-12-22 2014-12-10 Bracco Suisse S.A. Systeme de microvesicule remplie de gaz pour l'imagerie de contraste
JP4895151B2 (ja) * 2004-02-27 2012-03-14 日立金属株式会社 鉄系ナノサイズ粒子およびその製造方法
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20050260137A1 (en) 2004-05-18 2005-11-24 General Electric Company Contrast agents for magnetic resonance imaging
US20070031337A1 (en) 2004-06-22 2007-02-08 Reinhard Schulte Nanoparticle enhanced proton computed tomography and proton therapy
GB2415374A (en) 2004-06-25 2005-12-28 Leuven K U Res & Dev Targeted delivery of biologically active substances using iron oxide/gold core-shell nanoparticles
WO2006037081A2 (fr) * 2004-09-28 2006-04-06 The Regents Of The University Of California Radiosensibiliseurs a base de nanoparticules
EP1810688A1 (fr) 2004-11-10 2007-07-25 Konica Minolta Medical & Graphic, Inc. Préparation pharmaceutique contenant des particules magnétiques revêtues et procédé de fabrication idoine, et système de thérapie de diagnostic
US20070092927A1 (en) 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
WO2007052267A2 (fr) 2005-11-01 2007-05-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Composite biodegradable pour radiotherapie locale interne
US20070098640A1 (en) * 2005-11-02 2007-05-03 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography
KR100745744B1 (ko) * 2005-11-11 2007-08-02 삼성전기주식회사 나노 입자 코팅 방법
US20090130050A1 (en) 2006-03-24 2009-05-21 Toto Ltd. Titanium Oxide Composite Particles, Dispersion Liquid Thereof, and Process for Producing Them
WO2007116954A2 (fr) 2006-03-30 2007-10-18 Fujifilm Corporation Nanoparticule
EP1852107A1 (fr) 2006-04-19 2007-11-07 Nanobiotix Compositions contenant des nanoparticules magnétiques et leur utilisation
WO2008007290A2 (fr) 2006-07-10 2008-01-17 Philips Intellectual Property & Standards Gmbh nanoparticules à noyau/enveloppe à des fins de thérapie et d'imagerie
DE102006041495A1 (de) 2006-08-29 2008-03-20 Friedrich-Schiller-Universität Jena Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung
NO329127B1 (no) 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
NO20064315L (no) 2006-09-22 2008-03-24 Epitarget As T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav
EP1920784A1 (fr) 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Sensibilisateurs de radiation pour la thérapie par rayonnements ionisants et pour l'imagerie
US20090004258A1 (en) 2007-06-27 2009-01-01 National Health Research Institutes Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field
JP2009067613A (ja) 2007-09-11 2009-04-02 Fujifilm Corp コア−シェル型金属酸化物微粒子及びその製造方法
US20120176016A1 (en) * 2007-09-28 2012-07-12 General Electric Company Core-shell particulates, articles, and method of making
FR2922106B1 (fr) 2007-10-16 2011-07-01 Univ Claude Bernard Lyon Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
EP2067485A1 (fr) 2007-12-07 2009-06-10 Koninklijke Philips Electronics N.V. Transporteur de médicament fournissant un contraste amélioré pour l'IRM
US20100272639A1 (en) 2007-12-21 2010-10-28 John Robert Dutcher Polysaccharide nanoparticles
EP2242539B1 (fr) 2008-01-16 2015-04-01 Nanospectra Biosciences, Inc. Nanoparticules déclenchant une hyperthermie ciblée afin d'améliorer l'efficacité de radiothérapie
DE102008008522A1 (de) 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
WO2009142754A1 (fr) 2008-05-22 2009-11-26 Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Conjugués dendritiques et procédés associés
EP2130553A1 (fr) 2008-06-05 2009-12-09 Nanobiotix Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo
GB0811300D0 (en) * 2008-06-19 2008-07-30 Syngenta Participations Ag Methods of controlling neonicotinoid resistant insects
US20130023714A1 (en) 2008-10-26 2013-01-24 Board Of Regents, The University Of Texas Systems Medical and Imaging Nanoclusters
EP2275137A1 (fr) * 2009-07-10 2011-01-19 Nanobiotix Nanoparticules métalliques, leur préparation et utilisations
EP2305310A1 (fr) 2009-09-25 2011-04-06 Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE Glyconanoparticules magnétiques à revêtement en or fonctionnalisées pour une utilisation en tant qu'agents de diagnostic et de traitement
GB0921596D0 (en) 2009-12-09 2010-01-27 Isis Innovation Particles for the treatment of cancer in combination with radiotherapy
EP2537530A4 (fr) 2010-02-17 2015-12-16 Nat Univ Corp Univ Kobe Agent de radiothérapie
EP2555800B1 (fr) 2010-04-05 2018-03-21 Nanospectra Biosciences, Inc. Amélioration d'une thérapie par rayonnement par nanoparticules ciblées à z élevé
GB201009455D0 (en) 2010-06-04 2010-07-21 King S College London Nanoparticles and their uses in molecular imaging
WO2012104277A2 (fr) 2011-01-31 2012-08-09 Nanobiotix Procédé de surveillance de la libération par des liposomes d'un produit d'intérêt au moyen de nanoparticules superparamagnétiques
WO2012104275A2 (fr) 2011-01-31 2012-08-09 Nanobiotix Systèmes d'administration de nanoparticules, leur préparation et leurs utilisations
SG11201403096VA (en) 2011-12-16 2014-07-30 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
BR112015017490A2 (pt) 2013-01-25 2017-07-11 Nanobiotix uso de nanopartículas inorgânicas
US20140219926A1 (en) 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy
JP6387400B2 (ja) 2013-05-30 2018-09-05 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 医薬組成物、その製造および使用
MX2015017774A (es) 2013-06-20 2016-03-31 Nanobiotix Composiciones y metodos para el uso en el diagnostico medico.
SG11201510468TA (en) 2013-06-20 2016-01-28 Nanobiotix Compositions and methods for use in oncology
EP2886128A1 (fr) 2013-12-20 2015-06-24 Nanobiotix Compositions pharmaceutiques comportant des nanoparticules, leur préparation et leur utilisation

Also Published As

Publication number Publication date
JP6042450B2 (ja) 2016-12-14
WO2013087920A1 (fr) 2013-06-20
JP2015509079A (ja) 2015-03-26
US10945965B2 (en) 2021-03-16
CA2857260C (fr) 2019-10-15
SG11201403096VA (en) 2014-07-30
KR102025743B1 (ko) 2019-09-26
PL2790682T3 (pl) 2019-08-30
MA35851B1 (fr) 2014-12-01
EA029635B1 (ru) 2018-04-30
MX362089B (es) 2019-01-07
EP2790682B1 (fr) 2019-03-20
CA2857260A1 (fr) 2013-06-20
EA201491199A1 (ru) 2014-11-28
US20140335015A1 (en) 2014-11-13
CN104093401A (zh) 2014-10-08
AU2012351537A1 (en) 2014-07-24
IL233035B (en) 2018-02-28
AU2012351537B2 (en) 2017-03-02
KR20140108685A (ko) 2014-09-12
CN104093401B (zh) 2018-06-29
EP2790682A1 (fr) 2014-10-22
MX2014007131A (es) 2014-09-04
BR112014014412A2 (pt) 2017-06-13
IL233035A0 (en) 2014-07-31
NZ625848A (en) 2015-04-24

Similar Documents

Publication Publication Date Title
HK1203353A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
EP2726403A4 (fr) Matériaux hybrides et matériaux nanocomposites, leurs procédés de fabrication et leurs utilisations
EP2697162A4 (fr) Conceptions de nanoparticules multifonctionnelles et applications
PL3141528T3 (pl) Polikrystaliczny tlenek metalu, sposoby jego wytwarzania, i wyroby go zawierające
ZA201306464B (en) Nanoparticles delivery systems,preparation and uses thereof
EP2670549A4 (fr) Nanoparticules en métal lourd à surface modifiée, compositions et utilisations associées
EP2527346A4 (fr) Nanoparticule photoluminescente, sa préparation et son application
ZA201200902B (en) Metallic nanoparticles, preparation and uses thereof
IL229844B (en) Anti-psgl-1 antibodies and their use
EP2671855A4 (fr) Corps fritté d'oxyde et comprimés obtenus par traitement de celui-ci
EP2797843A4 (fr) Nanoparticules d'oxyde de lithium et de métal, leur procédé de préparation et leur utilisation
ZA201401210B (en) Peptide nanoparticles and uses thereof
PL2678244T3 (pl) Pakiet do parzenia i jego wytwarzanie
EP2868631A4 (fr) Poudre d'oxyde de zinc et procédé pour fabriquer celle-ci
EP2716359A4 (fr) Complexe et utilisations de celui-ci
PT2790739T (pt) Nanopartículas e utilizações das mesmas
PL2852537T3 (pl) Torebka do zaparzania i jej wytwarzanie
EP2766183A4 (fr) Composition de fibre de fer, sa préparation et ses utilisations
EP2774903A4 (fr) Matériau nanostructuré composé d'oxydes métalliques, procédé d'obtention et utilisation correspondante
HK1195563A1 (zh) 磷光材料的製備及其應用
GB201106357D0 (en) Composition and uses thereof
EP2693879A4 (fr) Migrastatines et leurs utilisations
EP2832818A4 (fr) Matières luminescentes dopées par des nanoparticules métalliques et leurs procédés de préparation
EP2594621A4 (fr) Matériaux luminescents à base d'oxydes et procédés de préparation associés
EP2607447A4 (fr) Matériaux luminescents à base de borate, leurs procédés de préparation et leurs utilisations